Hormonal

HCG

Prepared by the ezGLP team. Sources last checked September 5, 2026.

Also known as Human Chorionic Gonadotropin

Routes represented in the knowledgebase: Subcutaneous (SubQ).

Educational overview

HCG is listed in the ezGLP knowledgebase under Hormonal. Evidence and regulatory status can vary by formulation, route, and jurisdiction.

Category: Hormonal
Routes represented: Subcutaneous (SubQ)
Approximate library half-life: 33 hours; formulation-dependent and not dosing guidance
Storage context: Follow the dispensed product or pharmacy label; storage and beyond-use time vary by formulation.

Published literature

Safety evidence

Common or reported: headache, irritability, fatigue, edema, injection-site reactions, gynecomastia.

Serious or important: anaphylaxis, ovarian hyperstimulation syndrome, ovarian cyst complications, thromboembolism, fluid retention.

Safety evidence source

Summarised from published literature for reference only, with citations to the source. Evidence is graded as reported and is not a recommendation to combine, dose, or use any compound.

For personal tracking and education only. Not medical advice, diagnosis, or treatment, and not a medical device. Peptides may be prescription-only or unapproved where you live — consult a licensed healthcare professional.